Effect of Nirmatrelvir/Ritonavir (Paxlovid) on Hospitalization among Adults with COVID-19: an EHR-based Target Trial Emulation from N3C
Bhatia, A.; Preiss, A. J.; Xiao, X.; Brannock, M. D.; Alexander, G. C.; Chew, R. F.; Fitzgerald, M.; Hill, E.; Kelly, E. P.; Mehta, H. B.; Madlock-Brown, C.; Wilkins, K. J.; Chute, C. G.; Haendel, M.; Moffitt, R.; Pfaff, E. R.; The N3C Consortium,
Show abstract
This study leverages electronic health record data in the National COVID Cohort Collaboratives (N3C) repository to investigate disparities in Paxlovid treatment and to emulate a target trial assessing its effectiveness in reducing COVID-19 hospitalization rates. From an eligible population of 632,822 COVID-19 patients seen at 33 clinical sites across the United States between December 23, 2021 and December 31, 2022, patients were matched across observed treatment groups, yielding an analytical sample of 410,642 patients. We estimate a 65% reduced odds of hospitalization among Paxlovid-treated patients within a 28-day follow-up period, and this effect did not vary by patient vaccination status. Notably, we observe disparities in Paxlovid treatment, with lower rates among Black and Hispanic or Latino patients, and within socially vulnerable communities. Ours is the largest study of Paxlovids real-world effectiveness to date, and our primary findings are consistent with previous randomized control trials and real-world studies.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Measuring the missing: greater racial and ethnic disparities in COVID-19 burden after accounting for missing race/ethnicity data 92%
- Theoretical framework for retrospective studies of the effectiveness of SARS-CoV-2 vaccines 92%
- OpenSAFELY: Effectiveness of COVID-19 vaccination in children and adolescents. 91%
Similar papers in this journal
- Real-World Effectiveness Of Nirmatrelvir/Ritonavir On COVID-19-Associated Hospitalization Prevention: A Population-Based Cohort Study In The Province Of Québec, Canada 94%
- Pre-existing autoimmunity is associated with increased severity of COVID-19: A retrospective cohort study using data from the National COVID Cohort Collaborative (N3C) 93%
- Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET) 92%
Similar papers in this journal
- Protection of previous SARS-CoV-2 infection is similar to that of BNT162b2 vaccine protection: A three-month nationwide experience from Israel 93%
- Reduced risk of SARS-CoV-2 infection among household contacts with recent vaccination and past COVID-19 infection: results from two multi-site case-ascertained household transmission studies 92%
- Potential Biases in Test-Negative Design Studies of COVID-19 Vaccine Effectiveness Arising from the Inclusion of Asymptomatic Individuals 92%
Similar papers in this journal
- Benzodiazepine Initiation Effect on Mortality Among Medicare Beneficiaries Post Acute Ischemic Stroke 93%
- Safety Monitoring of Bivalent COVID-19 mRNA Vaccines Among Recipients 6 months and Older in the United States 92%
- Using quantitative bias analysis to adjust for misclassification of COVID-19 outcomes: An applied example of inhaled corticosteroids and COVID-19 outcomes 92%
Similar papers in this journal
- Effect of Early Treatment with Fluvoxamine on Risk of Emergency Care and Hospitalization Among Patients with COVID-19: The TOGETHER Randomized Platform Clinical Trial 94%
- Effectiveness of CoronaVac in the setting of high SARS-CoV-2 P.1 variant transmission in Brazil: A test-negative case-control study 93%
- Vaccination reduces need for emergency care in breakthrough COVID-19 infections: A multicenter cohort study 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.